Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sleep is an evolutionally conserved behavior from vertebrates to invertebrates. The molecular mechanisms that determine daily sleep amounts and the neuronal substrates for homeostatic sleep need remain unknown. Through a large-scale forward genetic screen of sleep behaviors in mice, we previously demonstrated that the
Sleepy
mutant allele of the
Sik3
protein kinase
gene markedly increases daily nonrapid-eye movement sleep (NREMS) amounts and sleep need. The
Sleepy
mutation deletes the in-frame exon 13 encoding a peptide stretch encompassing S551, a known
PKA
recognition site in SIK3. Here, we demonstrate that single amino acid changes at SIK3 S551 (
S551A
and
S551D
) reproduce the
hypersomnia
phenotype of the
Sleepy
mutant mice. These mice exhibit increased NREMS amounts and inherently increased sleep need, the latter demonstrated by increased duration of individual NREMS episodes and higher EEG slow-wave activity during NREMS. At the molecular level, deletion or mutation at SIK3 S551 reduces
PKA
recognition and abolishes 14-3-3 binding. Our results suggest that the evolutionally conserved S551 of SIK3 mediates, together with
PKA
and 14-3-3, the intracellular signaling crucial for the regulation of daily sleep amounts and sleep need at the organismal level.
...
PMID:A single phosphorylation site of SIK3 regulates daily sleep amounts and sleep need in mice. 3025 77